Copyright
©The Author(s) 2017.
World J Hepatol. Aug 8, 2017; 9(22): 959-966
Published online Aug 8, 2017. doi: 10.4254/wjh.v9.i22.959
Published online Aug 8, 2017. doi: 10.4254/wjh.v9.i22.959
n = 75 | |
Demographics | |
Age | 61.9 ± 16.6 |
Male gender | 43 (57.3) |
Race (Chinese/Malay/Indian) | 51/20/4 (68/26.7/5.3) |
Pre-existing co-morbidities | |
Pre-existing ischemic heart disease | 41 (54.7) |
Pre-existing cardiac failure | 27 (36.0) |
Pre-existing renal failure | 27 (36.0) |
Pre-existing chronic viral hepatitis | 5 (6.7) |
Precipitating conditions | |
Documented hypotension | 55 (73.3) |
Documented bradycardia | 11 (14.7) |
Documented metabolic acidosis | 43 (57.3) |
Baseline laboratory parameters1 | |
Albumin (g/L) | 25.3 ± 6.9 |
Bilirubin (μmol/L) | 76.1 ± 82.6 |
GGT (U/L) | 126 ± 90 |
Creatinine (mmol/L) | 321 ± 211 |
Prothrombin time (seconds) | 27.8 ± 12.2 |
ALT (U/L) | 2295 ± 1656 |
AST (U/L) | 4896 ± 2986 |
ALT/AST ratio_D12 | 0.70 ± 1.36 |
Peak ALT (U/L) | 2834 ± 1938 |
Peak AST (U/L) | 5894 ± 3148 |
Clinical outcome | |
Admitted to ICU | 50 (66.7) |
Died within same admission | 53 (70.7) |
- Citation: Chang PE, Goh BBG, Ekstrom V, Ong ML, Tan CK. Low serum albumin predicts early mortality in patients with severe hypoxic hepatitis. World J Hepatol 2017; 9(22): 959-966
- URL: https://www.wjgnet.com/1948-5182/full/v9/i22/959.htm
- DOI: https://dx.doi.org/10.4254/wjh.v9.i22.959